Related Experiment Video
Updated: May 26, 2026
Quantified Assessment of Infant's Gross Motor Abilities Using a Multisensor Wearable
Published on: May 17, 2024
Customised versus population-based growth charts as a screening tool for detecting small for gestational age infants
Angela E Carberry1, Adrienne Gordon, Diana M Bond
1RPA Newborn Care, RPA Women and Babies, Royal Prince Alfred Hospital and University of Sydney, School of Public Health, Missenden Road, Camperdown, Sydney, Australia, NSW 2050.
Insights
No randomized trials were found comparing customized versus population-based growth charts for screening fetal growth. Further research is needed to determine the benefits and harms of customized charts in pregnancy.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Neonatal Health
Background:
- Fetal growth restriction is a major pregnancy complication, often resulting in infants being small for gestational age (SGA).
- Identifying SGA infants is crucial due to their increased risk of perinatal morbidity and mortality.
- Current clinical assessment methods for SGA are insufficient; customized growth charts may better distinguish pathological from constitutional smallness.
Purpose of the Study:
- To evaluate the benefits and harms of using customized growth charts versus population-based growth charts for screening fetal growth in pregnant women.
Main Methods:
- Searched Cochrane Pregnancy and Childbirth Group's Trials Register, guidelines, and review articles.
- Included randomized, quasi-randomized, or cluster randomized trials comparing customized and population-based growth charts for fetal growth screening.
- Two authors independently assessed trial eligibility.
Main Results:
- No randomized trials met the inclusion criteria for this review.
Conclusions:
- Currently, there is no randomized trial evidence to support the use of customized growth charts over population-based charts.
- Further large-scale randomized trials are necessary to investigate the benefits and harms, including perinatal mortality, of customized growth charts in various settings and measurement methods.
Background:
Fetal growth restriction is defined as failure to reach growth potential and considered one of the major complications of pregnancy. These infants are often, although not universally, small for gestational age (SGA). SGA is defined as a weight less than a specified percentile (usually the 10th percentile). Identification of SGA infants is important because these infants are at increased risk of perinatal morbidity and mortality. Screening for SGA is a challenge for all maternity care providers and current methods of clinical assessment fail to detect many infants that are SGA. Large observational studies suggest that customised growth charts may be better able to differentiate between constitutional and pathologic smallness. Customised charts adjust for physiological variables such as maternal weight and height, ethnicity and parity.
Objectives:
To assess the benefits and harms of using population-based growth charts compared with customised growth charts as a screening tool for detection of fetal growth in pregnant women.
Search Methods:
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2011), reviewed published guidelines and searched the reference lists of review articles.
Selection Criteria:
Randomised, quasi-randomised or cluster randomised clinical trials comparing customised versus population-based growth charts used as a screening tool for detection of fetal growth in pregnant women.
Data Collection And Analysis:
Two review authors independently assessed trials for inclusion.
Main Results:
No randomised trials met the inclusion criteria.
Authors' Conclusions:
There is no randomised trial evidence currently available. Further randomised trials are required to accurately assess whether the improvement in detection shown is secondary to customised charts alone or an effect of the policy change. Future research in large trials is needed to investigate the benefits and harms (including perinatal mortality) of using customised growth charts in different settings and for both fundal height and ultrasound measurements.
Related Concept Videos
00:57Population Growth
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:52Regression Toward the Mean
01:30Preventive Healthcare Services